Programme and Speakers:

14h00 European perspective: parallel distribution of Centrally authorised products.
Legal framework, EMEA notification procedure, responsibilities for pharmacovigilance and quality defects, statistics and examples.

Pharm. Luc Van Santvliet, Scientific Administrator, European Medicines Agency


14h45 Belgian perspective
Belgian legislation (R.D. 19 April 2001), authorization procedure, conditions for approval, maintenance, ...

Pharm. Christine Putteman, Call Center Registration, AFMPS/FAGG

15h30 Coffee Break

16h00 Legal perspective
Parallel Trade Strategies of Innovative Life Science Companies in Exporting EEA Countries